HYUNDAI PHARMACEUTICAL CO., LTD.

ACTIVE

4/F, Seoul, 首尔特别市, South Koreawww.hyundaipharm.co.krPublic501–1,000 employeesEstablished: 1965-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1965

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

72.7%

Phase 3

18.2%

Phase 2

9.1%

Trial Status Distribution

Completed

81.8%

Unknown

18.2%

Clinical Trials

Trials sponsored by this organization (11)

HDDO-1756 Bio Equivalence Study

Phase 1

Completed

interventional

Jun 202056 participants

BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

Phase 3

Unknown

interventional

Feb 2020712 participants

Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis

Phase 3

Completed

interventional

Nov 2015244 participants

Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers

Phase 1

Completed

interventional

Apr 201425 participants

To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers

Phase 1

Completed

interventional

Oct 201324 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

HYUNDAI PHARMACEUTICAL CO., LTD.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (11)

HDDO-1756 Bio Equivalence Study

BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

HDDO-1801 Intervention Trial

HDDO-1614 Bio Equivalence Study

HDDO-1614 Intervention Trial

Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis

Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers

To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers

Approvals

News